"Blood Feud rivals A Civil Action for best non-fiction book of the past twenty years." -- John Lescroart, New York Times bestselling author of Damage Procrit seemed like a biotech miracle, promising a golden age in medical care. Developed in the 1980s by Amgen and licensed to the pharmaceutical giant, Johnson & Johnson, the drug (AKA Epogen and Aranesp) soon generated billions in annual revenue--and still does. In 2012, world famous cyclist, Olympian, and Tour de France champion Lance Armstrong was banned from professional cycling on doping charges for...
"Blood Feud rivals A Civil Action for best non-fiction book of the past twenty years." -- John Lescroart, New York Times bests...
